Article Information
History
- August 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- 1Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel
- 2Department of Health Policy and Management, Ben-Gurion University of the Negev, Beer Sheva, Israel
- ↵*Corresponding author:
Candace Makeda Moore, M.D., Research Coordinator, Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel Tel: (972) 52 353 1419; Fax: (972) 3 6916340; E-mail: doctormakeda{at}gmail.com
Posted August 18, 2021.
SARS-CoV-2 alpha variant: is it really more deadly? A population level observational study
